Why the study?
Does intrapericardial delivery of Astragaloside IV via a heart-derived extracellular matrix hydrogel improve microvascular regeneration and cardiac repair in a rat model of myocardial infarction?
Population
Rat myocardial infarction (MI) model and in vitro endothelial cells under oxygen-glucose deprivation
Design
Preclinical
Key result
AS-IV@HdECM hydrogel reduced myocardial infarct size to 15.4% and significantly improved cardiac function and microvascular regeneration in a rat myocardial infarction model.
Authors
Loading...
A novel heart-derived extracellular matrix hydrogel delivering Astragaloside IV intrapericardially promotes microvascular regeneration and cardiac repair in a preclinical myocardial infarction model.
Does intrapericardial delivery of Astragaloside IV via a heart-derived extracellular matrix hydrogel improve microvascular regeneration and cardiac repair in a rat model of myocardial infarction?
A novel heart-derived extracellular matrix hydrogel delivering Astragaloside IV intrapericardially promotes microvascular regeneration and cardiac repair in a preclinical myocardial infarction model.
Lan et al. (2026) studied Myocardial infarction. AS-IV@HdECM hydrogel vs. PBS (MI control), HdECM hydrogel alone, AS-IV alone was evaluated on Infarct size. AS-IV@HdECM hydrogel reduced myocardial infarct size to 15.4% and significantly improved cardiac function and microvascular regeneration in a rat myocardial infarction model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: